Drug Shortage Report for IMITREX

Last updated on 2018-06-27 History
Report ID 11234
Drug Identification Number 02212188
Brand name IMITREX INJECTION 12MG/ML
Common or Proper name Sumatriptan succinate injection
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) SUMATRIPTAN
Strength(s) 12MG
Dosage form(s) LIQUID
Route of administration SUBCUTANEOUS
Packaging size 5x0.5mL
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Shortage of an active ingredient.
Anticipated start date
Actual start date 2017-06-26
Estimated end date 2018-06-29
Actual end date 2018-06-26
Shortage status Resolved
Updated date 2018-06-27
Company comments Supply released July 2017 and August 2017 with limited quantity
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v36 2018-06-27 French Compare
v35 2018-06-27 English Compare
v34 2018-06-20 French Compare
v33 2018-06-20 English Compare
v32 2018-05-02 French Compare
v31 2018-05-02 English Compare
v30 2018-03-20 French Compare
v29 2018-03-20 English Compare
v28 2018-01-04 French Compare
v27 2018-01-04 English Compare
v26 2017-10-04 French Compare
v25 2017-10-04 English Compare
v24 2017-08-31 French Compare
v23 2017-08-31 English Compare
v22 2017-07-26 French Compare
v21 2017-07-26 English Compare
v20 2017-07-19 French Compare
v19 2017-07-19 English Compare
v18 2017-07-05 French Compare
v17 2017-07-05 English Compare

Showing 1 to 20 of 36